A 2:1 formulation of follitropin alfa and lutropin alfa in routine clinical practice: a large, multicentre, observational study
about
Cost-effectiveness analysis on the use of rFSH + rLH for the treatment of anovulation in hypogonadotropic hypogonadal women.A large, multicentre, observational, post-marketing surveillance study of the 2:1 formulation of follitropin alfa and lutropin alfa in routine clinical practice for assisted reproductive technology.Gonadotropin stimulation: past, present and future.
P2860
A 2:1 formulation of follitropin alfa and lutropin alfa in routine clinical practice: a large, multicentre, observational study
description
2010 nî lūn-bûn
@nan
2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
A 2:1 formulation of follitrop ...... lticentre, observational study
@ast
A 2:1 formulation of follitrop ...... lticentre, observational study
@en
type
label
A 2:1 formulation of follitrop ...... lticentre, observational study
@ast
A 2:1 formulation of follitrop ...... lticentre, observational study
@en
prefLabel
A 2:1 formulation of follitrop ...... lticentre, observational study
@ast
A 2:1 formulation of follitrop ...... lticentre, observational study
@en
P2860
P1476
A 2:1 formulation of follitrop ...... lticentre, observational study
@en
P2093
Klaus Bühler
Olaf Naether
P2860
P304
P356
10.3109/09513590.2010.511014
P577
2010-09-17T00:00:00Z